Drugs / PRO-067
last change Jul 2017 re-read 2 minutes ago

PRO-067

Developed for
ocular hypertension · open-angle glaucoma
Investigated by
Laboratorios Sophia S.A de C.V.

Trials 1 · a red edge is where a trial was stopped

20162017201820192020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT02801617 Sep 2015 → Mar 2017 ocular hypertension, open-angle glaucoma Laboratorios Sophia S.A de C.V. Terminated No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as PRO-067 ClinicalTrials.gov intervention name — accepted as the source's own label NCT02801617
Route Other “PRO-067 ophthalmic solution” NCT02801617